Arcadian Capital

Founded in 2017, Arcadian Capital is a growth capital firm based in Los Angeles. It invests thematically in early-to-mid-stage companies within secular growth markets, focusing primarily on consumer segments of the health and wellness industry.

Philippe Helderweirt

Partner and Co-Head of Europe

5 past transactions

Kadenwood

Series B in 2021
Kadenwood is a privately-held consumer products lifestyle company that specializes in cannabidiol (CBD) products aimed at establishing CBD as a trusted and safe option within the mainstream wellness market. The company is committed to quality by utilizing vertically-integrated CBD farming practices, allowing for the production of THC-free CBD oil from seed to shelf. Kadenwood's product offerings include sports creams, roll-ons, oil drops, pet health products, and organic hot teas, all of which comply with farm-bill regulations. Through its focus on quality and innovation, Kadenwood seeks to redefine the CBD industry and promote wellness among its consumers.

Petalfast

Series A in 2021
Petalfast Inc. is a sales and marketing company focused on the cannabis industry, providing a comprehensive suite of services designed to enhance brand visibility and drive growth. Founded in 2020 and based in Middletown, Delaware, Petalfast offers a range of marketing solutions, including brand strategy, graphic identity, packaging design, audience segmentation, retail strategy, and digital content creation. Their sales accelerator comprises six components that can be utilized independently or collectively to maximize impact. By leveraging its marketing expertise, Petalfast assists cannabis brands in developing effective sales strategies, optimizing their market reach, and implementing targeted advertising campaigns. The company's approach is tailored to meet the specific needs of clients in the cannabis sector, enabling them to navigate a competitive landscape and achieve sustainable growth.

Semasio

Series B in 2021
Founded in 2010, Semasio specializes in targeting solutions for programmatic advertising. It uses Natural Language Processing to analyze website content, generating user profiles that enable clients to create and address specific audiences. Headquartered in Hamburg with offices in New York, Denmark, and Portugal, Semasio serves global agency networks, advertisers, and media agencies.

Front Range Biosciences

Series B in 2019
Front Range Biosciences, Inc. is an agricultural biotechnology company focused on the breeding and production of innovative plants and seeds in the hemp, coffee, and cannabis sectors. Founded in 2015 and based in Lafayette, Colorado, the company specializes in tissue culture propagation and the development of high-value crops at scale, improving the consistency and efficiency of clone and seed production. Front Range Biosciences features a Clean Stock program which supplies disease- and pest-free plants to farmers while offering data-driven breeding solutions aimed at enhancing commercially relevant traits. The company also provides rooted cuttings, pre-finished plants, and feminized hemp seeds, enabling cultivators to increase yields, reduce disease prevalence, and develop novel strains, ultimately contributing to modern agricultural practices in these industries. Additional offices in Wisconsin, California, and Spain support its operations and research initiatives.

KelSie Biotech

Series A in 2019
Founded in 2017, KelSie Biotech specializes in the research and development of dry powder formulations for enhanced drug delivery. The company offers formulation services, licensing opportunities, trial design assistance, manufacturing capabilities, and consulting expertise to improve bioavailability of Active Pharmaceutical Ingredients (APIs). Its patented bubble drying process enables the creation of inhalable products and sublingual wafers, facilitating easier administration of everyday dosages.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.